Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: a micro‐simulation study of 230 scenarios
AM Getaneh, EAM Heijnsdijk, MJ Roobol… - Cancer …, 2020 - Wiley Online Library
Background Prostate cancer screening incurs a high risk of overdiagnosis and
overtreatment. An organized and age‐targeted screening strategy may reduce the …
overtreatment. An organized and age‐targeted screening strategy may reduce the …
Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios
AM Getaneh, EAM Heijnsdijk, MJ Roobol… - Cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Prostate cancer screening incurs a high risk of overdiagnosis and
overtreatment. An organized and age-targeted screening strategy may reduce the …
overtreatment. An organized and age-targeted screening strategy may reduce the …
Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios
AM Getaneh, EAM Heijnsdijk, MJ Roobol… - Cancer …, 2020 - abdn.elsevierpure.com
Background: Prostate cancer screening incurs a high risk of overdiagnosis and
overtreatment. An organized and age-targeted screening strategy may reduce the …
overtreatment. An organized and age-targeted screening strategy may reduce the …
[HTML][HTML] Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
AM Getaneh, EAM Heijnsdijk, MJ Roobol… - Cancer …, 2020 - ncbi.nlm.nih.gov
Background Prostate cancer screening incurs a high risk of overdiagnosis and
overtreatment. An organized and age‐targeted screening strategy may reduce the …
overtreatment. An organized and age‐targeted screening strategy may reduce the …
Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios.
AM Getaneh, EAM Heijnsdijk, MJ Roobol… - Cancer …, 2020 - search.ebscohost.com
Background: Prostate cancer screening incurs a high risk of overdiagnosis and
overtreatment. An organized and age‐targeted screening strategy may reduce the …
overtreatment. An organized and age‐targeted screening strategy may reduce the …
Assessment of harms, benefits, and cost‐effectiveness of prostate cancer screening: A micro‐simulation study of 230 scenarios
AM Getaneh, EAM Heijnsdijk, MJ Roobol… - Cancer …, 2020 - search.proquest.com
Background Prostate cancer screening incurs a high risk of overdiagnosis and
overtreatment. An organized and age‐targeted screening strategy may reduce the …
overtreatment. An organized and age‐targeted screening strategy may reduce the …
[PDF][PDF] Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios
AM Getaneh, EAM Heijnsdijk, MJ Roobol - Cancer Medicine, 2020 - scholar.archive.org
1| BACKGROUND The incidence of prostate cancer has increased in most European
countries, whereas prostate cancer mortality rates have declined. 1, 2 Most Western …
countries, whereas prostate cancer mortality rates have declined. 1, 2 Most Western …
Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: a micro-simulation study of 230 scenarios.
AM Getaneh, EAM Heijnsdijk, MJ Roobol… - 2020 - cabidigitallibrary.org
Background: Prostate cancer screening incurs a high risk of overdiagnosis and
overtreatment. An organized and age-targeted screening strategy may reduce the …
overtreatment. An organized and age-targeted screening strategy may reduce the …
Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios.
AM Getaneh, EAM Heijnsdijk, MJ Roobol… - Cancer …, 2020 - europepmc.org
Background Prostate cancer screening incurs a high risk of overdiagnosis and
overtreatment. An organized and age-targeted screening strategy may reduce the …
overtreatment. An organized and age-targeted screening strategy may reduce the …
Assessment of harms, benefits, and cost-effectiveness of prostate cancer screening: A micro-simulation study of 230 scenarios
AM Getaneh, E Heijnsdijk, M Roobol-Bouts… - Cancer …, 2020 - repub.eur.nl
Background: Prostate cancer screening incurs a high risk of overdiagnosis and
overtreatment. An organized and age-targeted screening strategy may reduce the …
overtreatment. An organized and age-targeted screening strategy may reduce the …